The performance and economics of any bioprocess are significantly impacted by the choice of host platform. Ingenza’s diverse range of bacterial, yeast and mammalian production platforms is an excellent foundation for biomanufacturing development.
In this white paper, Rita Cruz, Section Head of Strain Development at Ingenza, explores the numerous advantages of Ingenza’s Gram-positive Bacillus subtilis platform for recombinant protein production, including a proprietary gene design algorithm and strains with improved performance.
Check out our team page to learn more about Rita and her work at Ingenza.
To access this content, please fill in your details below.